(Q31140261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

main subject

Gram-negative bacteria

0 references

author

Paul D. Cotter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Colin Hill

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Reynolds Paul Ross

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Catherine Stanton

1 reference

ORCID Public Data File 2021

author name string

Lorraine A Draper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

26 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells

23 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

The "other" gram-negative bacteria in mastitis: Klebsiella, serratia, and more

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Structure--activity relationships of polymyxin antibiotics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Lantibiotics: mode of action, biosynthesis and bioengineering

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Mammary pathogenic Escherichia coli

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Biosynthesis and mode of action of lantibiotics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

The bacterial outer membrane as a drug barrier

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Roles of antibodies and complement in phagocytic killing of enterococci

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Agents that increase the permeability of the outer membrane.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Polymyxin and Related Peptide Antibiotics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Discovery of medically significant lantibiotics.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Lacticin 3147--biosynthesis, molecular analysis, immunity, bioengineering and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Synergistic effects of miconazole and polymyxin B on microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Colistin: new lessons on an old antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-13-212

Bacteriocins - a viable alternative to antibiotics?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

Eradication of early Pseudomonas aeruginosa infection

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849175

The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II

25 November 2018

1 reference

12 December 2020

Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms

1 reference

12 December 2020

Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis

1 reference

12 December 2020

Efficacy of Organic Acids, Bacteriocins, and the Lactoperoxidase System in Inhibiting the Growth of Cronobacter spp. in Rehydrated Infant Formula

1 reference

12 December 2020

Nisin A and Polymyxin B as Synergistic Inhibitors of Gram-positive and Gram-negative Bacteria

1 reference

12 December 2020

Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria

1 reference

12 December 2020

[Clinical use of colimycin F otic solution]

1 reference

12 December 2020

[The use of colimycin ear drops]

1 reference

12 December 2020

Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2180-13-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

24069959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24069959%20AND%20SRC:MED&resulttype=core&format=json